Growth hormone releasing peptides: growth studies
- 1 April 1999
- journal article
- growth and-development
- Published by Ovid Technologies (Wolters Kluwer Health) in Current Opinion in Endocrinology, Diabetes and Obesity
- Vol. 6 (2), 100-105
- https://doi.org/10.1097/00060793-199904000-00003
Abstract
Although recombinant human growth hormone (GH) remains the gold standard for treatment of GH-deficient (GHD) children, growth hormone releasing hormone is also approved for this indication. The discovery of the growth hormone releasing peptides (GHRPs) and the highly conserved growth hormone secretagogue (GHS) receptor suggests the existence of an as yet unidentified endogenous ligand involved in the control of GH secretion. Published efficacy data on the use of GH secretagogues (GHRP and GHRP-mimetics) in children with GHD are limited, but suggest that GHSs increase growth velocity compared to pretreatment. However, in these small studies of relatively short duration, growth was less than that seen historically with GH treatment. It is unknown whether, at least in a subset of patients, genetic height potential can be attained with GHS. As the physiologic role of the putative GHS ligand is clarified, any potential therapeutic role for GHS therapy in a subset of children with GHD may become more clear.Keywords
This publication has 31 references indexed in Scilit:
- Pharmacokinetics and Pharmacodynamics of Growth Hormone-Releasing Peptide-2: A Phase I Study in ChildrenJournal of Clinical Endocrinology & Metabolism, 1998
- A Receptor in Pituitary and Hypothalamus That Functions in Growth Hormone ReleaseScience, 1996
- Absence of growth hormone (GH) secretion after the administration of either GH-releasing hormone (GHRH), GH-releasing peptide (GHRP-6), or GHRH plus GHRP-6 in children with neonatal pituitary stalk transectionJournal of Clinical Endocrinology & Metabolism, 1995
- Growth hormone (GH)-releasing effects of synthetic peptide GH-releasing peptide-2 and GH-releasing hormone (1-29NH2) in children with GH insufficiency and idiopathic short statureMetabolism, 1995
- Design and biological activities of L-163,191 (MK-0677): a potent, orally active growth hormone secretagogue.Proceedings of the National Academy of Sciences of the United States of America, 1995
- Growth hormone (GH) responses to GH-releasing peptide and to GH- releasing hormone in GH-deficient childrenJournal of Clinical Endocrinology & Metabolism, 1995
- Pituitary 1Journal of Endocrinology, 1995
- Growth hormone (GH)-releasing hormone secretion is stimulated by a new GH-releasing hexapeptide in sheepEndocrinology, 1994
- Growth hormone response in man to L-692,429, a novel nonpeptide mimic of growth hormone-releasing peptide-6Journal of Clinical Endocrinology & Metabolism, 1993
- A Study on the Regulation of Growth Hormone Release from the Pituitaries of Rats in Vitro*Endocrinology, 1981